Orlia develops an all-in-one sensing platform that enables rapid measurement of lipids, proteins, and cell characteristics at the cellular level. This technology enhances cell health and increases yield in bioreactors and fermenters, providing results in minutes to optimize biological production systems.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for monitoring cell health and optimizing yield in bioreactors and fermenters often involve time-consuming lab assays and provide limited insight into cellular-level characteristics. This can lead to suboptimal process control, reduced production efficiency, and delayed detection of potential issues affecting cell viability and productivity.
Solution
Orlia offers a comprehensive sensing platform that enables rapid, real-time measurement of key cellular parameters directly within bioreactors and fermenters. The system provides detailed information on lipids, proteins, cell count, cell phase, and morphology at the cellular level, delivering results in minutes. By providing immediate access to critical data, Orlia's technology empowers users to optimize biological production systems, enhance cell health, and increase overall yield. The all-in-one design simplifies the monitoring process, eliminating the need for complex sample preparation and external laboratory analysis.
Target Audience
The primary target audience includes biopharmaceutical companies, food and beverage manufacturers, and research institutions utilizing bioreactors and fermenters for cell-based production processes.
Features
- Integrated sensor technology for simultaneous measurement of lipids, proteins, cell count, phase, and morphology
- Real-time data acquisition and analysis, providing results within minutes
- Non-invasive monitoring directly within bioreactors and fermenters
- User-friendly software interface for data visualization and process control
- Compact, all-in-one system design for easy integration into existing workflows